Avian Chlamydiosis (Psittacosis): Zoonotic Risks and Diagnostic Approaches in Pet Birds

Introduction

Avian chlamydiosis, historically termed psittacosis or ornithosis, is a systemic bacterial infection of birds caused primarily by Chlamydia psittaci, an obligate intracellular Gram-negative bacterium with a unique biphasic developmental cycle [1]. The disease affects over 450 avian species across 30 orders, with psittacine birds (parrots, cockatiels, budgerigars) serving as the most recognized reservoir [1, 2]. C. psittaci is a zoonotic pathogen capable of causing severe respiratory illness in humans, designated psittacosis, which can be fatal if untreated [1, 3]. The pathogen is transmitted horizontally among birds via inhalation of aerosolized fecal dust, respiratory secretions, and feather dust, and occasionally through fomites [1, 4]. Cross-species transmission to humans occurs primarily through direct contact with infected birds or contaminated environments [1, 5]. Recent evidence confirms rare human-to-human transmission [1]. This article provides an exhaustive review of the zoonotic risks associated with C. psittaci in pet birds and the diagnostic modalities available for its detection, with emphasis on polymerase chain reaction (PCR), serology, and culture. Treatment guidelines centered on doxycycline are discussed within the context of infection control.

Etiology and Pathogenesis

Chlamydia psittaci belongs to the family Chlamydiaceae and is characterized by a biphasic developmental cycle alternating between infectious elementary bodies (EBs) and metabolically active reticulate bodies (RBs) [1]. EBs are environmentally stable and facilitate transmission, while RBs replicate within host cell inclusions. The organism possesses a type III secretion system and polymorphic membrane proteins (Pmps) that mediate adhesion and host cell invasion [63]. The major outer membrane protein (MOMP), encoded by the ompA gene, is a key immunogen and target for genotyping [1, 62]. At least 15 genotypes (A through F, E/B, 1V, Mat116, M56, and others) have been described, with genotype A most commonly associated with psittacine birds and human disease [1, 4, 64]. Genotype B is frequently found in pigeons and has been identified in waterfowl and poultry [53, 64]. Emerging species such as Chlamydia gallinacea, Chlamydia avium, and Chlamydia ibidis have been detected in birds and may contribute to the disease spectrum [6, 53, 62, 88].

Infection in birds typically begins with inhalation or ingestion of EBs, followed by replication in respiratory epithelium and macrophages, leading to systemic dissemination to the liver, spleen, and other organs [1, 2]. Clinical signs range from subclinical carriage to severe disease with conjunctivitis, rhinitis, dyspnea, diarrhea, lethargy, and mortality [1, 60]. Stress factors such as overcrowding, poor nutrition, and concurrent infections (e.g., circovirus, adenovirus) exacerbate disease severity [7, 60, 70]. Histopathologic lesions include fibrinous airsacculitis, hepatomegaly with necrosis, splenomegaly, and meningoencephalitis [8, 60]. Immunohistochemistry and fluorescence in situ hybridization (FISH) can demonstrate intracytoplasmic inclusions in affected tissues [60, 61].

Zoonotic Risks

C. psittaci is classified as a biosafety level 3 pathogen and is considered a potential biological warfare agent [3, 9]. Human infection, psittacosis, typically presents as an influenza-like illness with fever, headache, and dry cough, progressing to atypical pneumonia; severe cases may involve encephalitis, myocarditis, and death if untreated [1, 3]. The mortality rate in untreated human cases ranges from 5% to 40% [3]. Occupational exposure is a major risk for pet bird owners, veterinary staff, aviary workers, and poultry processors [1, 3, 5, 84]. Environmental contamination with C. psittaci has been documented in pet stores and breeding facilities, with positive environmental swabs from cages, mops, and tables [4]. The pathogen can survive in dried feces and dust for months, facilitating indirect transmission [1, 4].

The prevalence of C. psittaci in pet birds varies geographically. A study in Thailand reported a 2.5% prevalence in psittacine birds using PCR targeting the ompA gene [10]. In Guangxi, China, overall avian chlamydial positivity was 28.2% across poultry and pet birds, with pet birds showing 40.4% positivity [53]. In Belgium, a study of psittacine pet birds and their owners found C. psittaci DNA in 8.3% of birds and 5% of human contacts [79, 106]. Asymptomatic carriage is common, and birds may shed the organism intermittently, especially under stress [10, 157]. The zoonotic risk is heightened by the fact that infected birds may appear healthy yet excrete EBs [10, 157]. Therefore, routine screening of pet birds, especially those in contact with immunocompromised individuals, is recommended [5, 11].

Diagnostic Approaches

Accurate diagnosis of avian chlamydiosis is essential for treatment and zoonotic risk mitigation. The diagnostic arsenal includes direct detection methods (PCR, culture, antigen detection) and indirect serological assays. The choice of test depends on the clinical context, sample type, and laboratory capability.

Polymerase Chain Reaction (PCR)

PCR has become the gold standard for detecting C. psittaci due to its high sensitivity, specificity, and rapid turnaround time [1, 10, 62]. Real-time PCR assays targeting the ompA gene, 16S rRNA gene, or the 23S rRNA gene are widely used [62, 115]. Multiplex real-time PCR assays can differentiate between C. psittaci, C. avium, and C. gallinacea in a single reaction, which is valuable given the emergence of these species [62]. The assay developed by Lee et al. [62] demonstrated high efficiency (94.8–100.7%) and a detection limit of fewer than 10 copies per reaction. Another species-specific real-time PCR for C. psittaci was employed to investigate zoonotic transmission from racing pigeons in Denmark [115]. PCR can be performed on oropharyngeal swabs, choanal swabs, conjunctival swabs, feces, and environmental samples [10, 4, 141]. For postmortem diagnosis, liver, spleen, and lung tissues are preferred [60, 61]. The sensitivity of PCR is superior to culture and antigen detection, especially in subclinical carriers [77]. Genotyping of C. psittaci by sequencing the ompA gene or by multilocus sequence typing (MLST) provides epidemiological information and helps trace infection sources [1, 64, 101, 114].

Serology

Serological tests detect antibodies against C. psittaci and are useful for population screening and retrospective diagnosis. The complement fixation test (CFT) was historically used but has been largely replaced by enzyme-linked immunosorbent assays (ELISA) and indirect immunofluorescence assays (IFA) [46, 66]. Commercial ELISA kits detect anti-Chlamydia antibodies in avian sera, but cross-reactivity with other chlamydial species can occur [46]. A study in Bangladesh using a sandwich-ELISA found a 6.6% seroprevalence in pigeons [12]. Serology is less reliable for individual diagnosis in acute infection because antibodies may not appear until 7–14 days post-infection, and previous exposure can yield positive results in the absence of active shedding [5, 44]. Paired serology (acute and convalescent) improves diagnostic accuracy but is rarely practical in clinical settings. In human psittacosis, serology (microimmunofluorescence) remains a mainstay, but for avian diagnosis, PCR is preferred [1, 5].

Culture

Isolation of C. psittaci in cell culture or embryonated chicken eggs is the definitive diagnostic method but is technically demanding, time-consuming, and requires biosafety level 3 facilities [9, 13]. Cell lines such as McCoy, BGM, and Vero cells are used, with detection of intracytoplasmic inclusions by staining (e.g., Giemsa, modified Gimenez, or immunofluorescence) [13, 59]. Culture is less sensitive than PCR, especially when samples contain few viable organisms or when birds have been treated with antibiotics [44]. However, culture is essential for obtaining isolates for genotyping, antimicrobial susceptibility testing, and research [64, 101]. In the context of pet birds, culture is rarely performed in first-line diagnostics and is reserved for reference laboratories.

Other Diagnostic Methods

Antigen detection tests, including direct immunofluorescence (DFA) and rapid immunochromatographic assays, are available but have lower sensitivity than PCR [79, 80]. A rapid cassette test for MOMP antigen showed 40% positivity in pigeon oropharyngeal swabs, but only 8.3% of those were confirmed by PCR [79]. Histopathology with immunohistochemistry (IHC) or FISH can detect chlamydial inclusions in formalin-fixed tissues, providing a valuable adjunct for postmortem diagnosis [60, 61]. FISH targeting the MOMP gene demonstrated 67% positivity in avian liver sections, with good correlation to PCR [61]. Modified Gimenez staining of smears from conjunctiva or cloaca is a rapid screening method but lacks specificity [13].

Diagnostic Decision Tree

The following Mermaid diagram outlines a diagnostic workflow for suspected avian chlamydiosis in pet birds.

flowchart TD
    A[Clinical suspicion: respiratory signs, conjunctivitis, lethargy], > B{Collect samples}
    B, > C[Oropharyngeal/choanal swab for PCR]
    B, > D[Conjunctival swab for PCR]
    B, > E[Feces for PCR]
    B, > F[Blood for serology]
    C, > G{Real-time PCR for Chlamydiaceae}
    G, > H[Positive: C. psittaci, C. avium, or C. gallinacea]
    G, > I[Negative: consider other pathogens]
    H, > J[Genotyping ompA/MLST for epidemiology]
    H, > K[Initiate doxycycline treatment]
    I, > L[Repeat PCR if high suspicion; consider culture]
    F, > M[ELISA or IFA for antibodies]
    M, > N[Positive: indicates exposure; not definitive for active infection]
    M, > O[Negative: does not rule out early infection]
    K, > P[Monitor clinical response; re-test PCR after treatment]

Treatment and Control

Doxycycline is the antimicrobial of choice for treating avian chlamydiosis [5, 153]. The recommended regimen for psittacine birds is oral doxycycline at 25–50 mg/kg once daily for 45 days, or doxycycline-medicated feed (e.g., 1 mg/g feed) for the same duration [5, 153]. Injectable doxycycline (e.g., 50–100 mg/kg intramuscularly every 5–7 days) can be used in birds that cannot tolerate oral medication [5]. Treatment must be continued for the full course to eliminate the organism, as C. psittaci can persist intracellularly [1, 5]. In large outbreaks, in-feed doxycycline is practical [4]. Environmental decontamination is critical: thorough cleaning with disinfectants effective against chlamydiae (e.g., quaternary ammonium compounds, 1% bleach) and repeated environmental PCR testing to confirm clearance [4, 5]. Quarantine of new birds, routine screening, and biosecurity measures reduce the risk of introduction and spread [10, 5]. No commercial vaccine is currently available for birds, although experimental vaccines (e.g., DNA vaccines, recombinant herpesvirus of turkeys expressing PmpD) have shown promise [52, 132, 158].

Conclusion

Avian chlamydiosis remains a significant zoonotic threat in pet bird populations. Chlamydia psittaci is the primary causative agent, but emerging species expand the diagnostic landscape. PCR-based methods, particularly real-time multiplex assays, offer the most sensitive and specific approach for detection and differentiation. Serology and culture retain roles in specific contexts. Doxycycline therapy for 45 days, combined with environmental decontamination, is the cornerstone of control. Veterinary professionals must maintain a high index of suspicion in birds with respiratory or systemic signs and implement appropriate diagnostic testing to protect both avian and human health.

References

[1] Wang J, Wang B, Xiao J, et al. Chlamydia psittaci: A zoonotic pathogen causing avian chlamydiosis and psittacosis. Virulence. 2024. https://www.semanticscholar.org/paper/9c0792b90a401644c2b95f238c871d740d15945a

[2] Vanrompay D, Ducatelle R, Haesebrouck F. Chlamydia psittaci infections: a review with emphasis on avian chlamydiosis. Vet Microbiol. 1995. https://www.semanticscholar.org/paper/8c4e67be8c47e252f9e485b635c411d7b1d3884a

[3] Ravichandran K, Anbazhagan S, Karthik K, et al. A comprehensive review on avian chlamydiosis: a neglected zoonotic disease. Trop Anim Health Prod. 2021. https://www.semanticscholar.org/paper/b07a3df257c6e9a8db3bc2626897c403ac2c7705

[4] Bonwitt J, Riethman M, Glashower D, et al. Application of environmental sampling to investigate a case of avian chlamydiosis in a pet store and breeding facility leading to mass bird exposures. Zoonoses Public Health. 2023. https://www.semanticscholar.org/paper/41dcc9e1ac42c9cc9546895e39eafd1060161679

[5] Balsamo G, Maxted A, Midla J, et al. Compendium of Measures to Control Chlamydia psittaci Infection Among Humans (Psittacosis) and Pet Birds (Avian Chlamydiosis), 2017. J Avian Med Surg. 2017. https://www.semanticscholar.org/paper/293acad5a26a6a6c26716b3342302e5a5aa9070f

[6] Sachse K, Laroucau K. Avian chlamydiosis: two more bacterial players discovered. Vet J. 2014. https://www.semanticscholar.org/paper/e2489ba312a242c62ed021143555661bd326a838

[7] To K, Tse H, Chan W, et al. A Novel Psittacine Adenovirus Identified During an Outbreak of Avian Chlamydiosis and Human Psittacosis: Zoonosis Associated with Virus-Bacterium Coinfection in Birds. PLoS Negl Trop Dis. 2014. https://www.semanticscholar.org/paper/b6a6bdc2182fa3c8f5d6bfed8640e1f2c235a966

[8] Šatrović E, Krkalić L, Ćutuk A, et al. PATHOMORPHOLOGICAL AND HISTOPATHOLOGICAL CHANGES OF AVIAN CHLAMYDIOSIS. 2011. https://www.semanticscholar.org/paper/34e8899c3e98a22e8cdda4ac5f5a916c07e17a5a

[9] Dickx V, van Droogenbroeck C, Van Vaerenbergh B, et al. Chlamydia Psittaci, Causative Agent of Avian Chlamydiosis and Human Psittacosis: Risk Assessment and Biosafety Recommendations for Laboratory use. 2012. https://www.semanticscholar.org/paper/35300983313ed43a95bf0020fcceea32d9b82c51

[10] Tripinichgul S, Weerakhun S, Kanistanon K. Prevalence and Risk Factors of Avian Chlamydiosis Detected by Polymerase Chain Reaction in Psittacine Birds in Thailand. J Avian Med Surg. 2023. https://www.semanticscholar.org/paper/c1d890a3caa2f54aafb5bb73632acf633bb16df4

[11] Smith KA. Compendium of Measures to Control Chlamydophila psittaci Infection Among Humans (Psittacosis) and Pet Birds (Avian Chlamydiosis), 2010 National Association of State Public Health Veterinarians (NASPHV). 2011. https://www.semanticscholar.org/paper/21a763f03f74e727901fcfe868443ff53e926e86

[12] Kulsum U, Hossain D, Hoque A, et al. Seroprevalence and Risk Factors Associated to Avian Chlamydiosis Among Pigeons in Bangladesh: First Known Evidence. Adv Anim Vet Sci. 2021. https://www.semanticscholar.org/paper/133763154dd69f4c032efa161fce7698946bd417

[13] Vanrompay D, Ducatelle R, Haesebrouck F. Diagnosis of avian chlamydiosis: specificity of the modified Giménez staining on smears and comparison of the sensitivity of isolation in eggs and three different cell cultures. Zentralbl Veterinarmed B. 1992. https://www.semanticscholar.org/paper/3c0aa7680f16c398184fb5e7ed74983901302559

[14] Santos B, Santos EA, Pereira DC, et al. Determining the Prevalence of Avian Chlamydiosis in Wild Amazona Species From Brazil Using Molecular Testing and Clinical Signs. J Avian Med Surg. 2023. https://www.semanticscholar.org/paper/89175e44d6bec8694a495be29fe9b85dfba87463

[15] Kanatlı Klamidyozu, et al. Avian chlamydiosis. CABI Compendium. 2022. https://www.semanticscholar.org/paper/5e2c0a08fc36fc4161543b65735acad8320e2451

[16] El-Ghany WA. Avian Chlamydiosis: A World-wide Emerging and Public Health Threat. 2020. https://www.semanticscholar.org/paper/d28e166fd45faae10af113615f324c1d72eb8bc0

[17] Malik Y, Milton AAP, Ghatak S, et al. Avian Chlamydiosis (Psittacosis, Ornithosis). Livestock Diseases and Management. 2021. https://www.semanticscholar.org/paper/7255621dd74b3d2d49f561244d11ba1cd6544ebe

[18] Szymańska-Czerwińska M, Niemczuk K. Avian Chlamydiosis Zoonotic Disease. Vector Borne Zoonotic Dis. 2016. https://www.semanticscholar.org/paper/e64334cbc1db719a2a40528613e513e539f282a5

[19] Hunt C. How I deal with avian chlamydiosis and aspergillosis. 2017. https://www.semanticscholar.org/paper/bfbae725ad9e353ee1ac4b04e6749735daed2085

[20] Heijne M. Avian chlamydiosis in chickens: from cell to population. https://www.semanticscholar.org/paper/39bffd406f0ff753692784c194be5aef3aa8629d

[21] Dhama K, Chakraborty S, Tiwari R, et al. Avian chlamydiosis (psittacosis/ornithosis): diagnosis, prevention and control, and its zoonotic concerns. 2013. https://www.semanticscholar.org/paper/e9d5a1e325c829bc31d93e4c7b770f19a438c398

[22] Avian Chlamydiosis. Psittacosis / Avian Chlamydiosis Ornithosis, Parrot Fever. 2013. https://www.semanticscholar.org/paper/c17f581c55a8f38d7365623d34c03b46ba971a74

[23] Docherty D, Franson J, Brannian R, et al. Avian botulism and avian chlamydiosis in wild water birds, Benton Lake National Wildlife Refuge, Montana, USA. J Zoo Wildl Med. 2012. https://www.semanticscholar.org/paper/416a5ec1eb1d9555c1bf6c1c8c542c73a7061c7e

[24] Šatrović E, Goletić T, Rešidbegović E, et al. Avian chlamydiosis in turkeys (Meleagris gallopavo) in Bosnia and Herzegovina. 2012. https://www.semanticscholar.org/paper/b072bc4af98cb1841c2ccc5c197fe4365017640e

[25] Eidson M. Psittacosis/avian chlamydiosis. J Am Vet Med Assoc. 2002. https://www.semanticscholar.org/paper/e005d71590cbaf1910a268d56ca603959fb7d97c

[26] Broome CV, Hewitt SMA, Higgins MM, et al. Compendium of measures to control Chlamydia psittaci infection among humans (psittacosis) and pet birds (avian chlamydiosis), 1998. MMWR Recomm Rep. 1998. https://www.semanticscholar.org/paper/0cca48a5039a638ab95164789ffea2c803b17db4

[27] 奥田 秀子. Studies on epidemiology of avian chlamydiosis and establishment of the diagnostic system for Chlamydia psittaci infection. 2012. https://www.semanticscholar.org/paper/9d332de30fad5be921b9acb444562ead765e746a

[28] Valkenburgh S, De Rosa M, Spierenburg M. [Avian chlamydiosis (parrot disease, psittacosis, ornithosis)]. Tijdschr Diergeneeskd. 2012. https://www.semanticscholar.org/paper/a5235c8e6643686b598f08f0cfcd5ffe2cadee5e

[29] Mensur V. EPIZOOTIOLOŠKA SLIKA AVIJARNE KLAMIDIOZE U BOSNI I HERCEGOVINI. 2011. https://www.semanticscholar.org/paper/53c3cbf2c5f4e9726615c7750c6ccadb6c154ac1

[30] Šatrović E, Hadžiomerović Z, Krkalić L, et al. EPIZOOTIOLOGICAL CHART OF AVIAN CHLAMYDIOSIS IN BOSNIA AND HERZEGOVINA. 2011. https://www.semanticscholar.org/paper/e916a2c3e14908cec4bf62bab0b5e566fec36d26

[31] Laroucau K, Trichereau A, Vorimore F, et al. A pmp genes-based PCR as a valuable tool for the diagnosis of avian chlamydiosis. Vet Microbiol. 2007. https://www.semanticscholar.org/paper/a543377682839c07abfff67ed0522e739d183800

[32] Butler JC, Whitney CG. Compendium of measures to control Chlamydia psittaci infection among humans (Psittacosis) and pet birds (Avian chlamydiosis), 1998. 1998. https://www.semanticscholar.org/paper/c81032286169f865bdf15b3e20135a67f05eba8e

[33] Centers for Disease Control and Prevention. Compendium of measures to control Chlamydia psittaci infection among humans (psittacosis) and pet birds (avian chlamydiosis), 2000. MMWR Recomm Rep. 2000. https://www.semanticscholar.org/paper/4